Bio-Techne
Angela Chen currently serves as Vice President and General Manager for the Asia-Pacific region at Bio-Techne since April 2025. Prior roles include Chief Business Officer and Asia General Manager at WuXi Advanced Therapies (April 2023 - April 2025) and China General Manager at WuXi AppTec Advanced Therapies Unit (January 2021 - April 2023). Angela held the CEO position at Porton Biologics Ltd. for a brief period in late 2020 and served as a Global Commercial & Strategy Leader at Cytiva and GE Healthcare from 2015 to 2020. Previous experience also includes leadership roles at Sigma Aldrich, HD Biosciences, and Merck. Angela holds an MBA from the University of Pittsburgh Katz Graduate School of Business and a PhD in Human Genetics from the University of Pittsburgh, along with a BS in Biochemistry from Fudan University.
This person is not in any teams
This person is not in any offices